Mechanistically, augmented phospho-SMAD1/5/9 (pSMAD1/5/9) binds to the tumor suppresser p53 protein, thus preventing p53 degradation from forming complexes with ubiquitin ligase murine double minute 2 (MDM2) (Hayano et al., 2015). The gene discussed is TP53; the disease is neoplasm.